| Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities N Cosgrove, D Varešlija, S Keelan, A Elangovan, JM Atkinson, ... Nature communications 13 (1), 514, 2022 | 51 | 2022 |
| Utility of self-destructing CRISPR/Cas constructs for targeted gene editing in the retina. MF Li, DSSC Hung, MMKNM Khalid, DJH Wang, DV Chrysostomou, ... Human Gene Therapy, 2019 | 34 | 2019 |
| Single-cell profiling identifies key pathways expressed by iPSCs cultured in different commercial media M Daniszewski, Q Nguyen, HS Chy, V Singh, DE Crombie, T Kulkarni, ... Iscience 7, 30-39, 2018 | 21 | 2018 |
| Integrating genetic structural variations and whole-genome sequencing into clinical neurology X Lin, Y Yang, PE Melton, V Singh, S Simpson-Yap, KP Burdon, BV Taylor, ... Neurology: Genetics 8 (4), e200005, 2022 | 11 | 2022 |
| Generation of a human induced pluripotent stem cell line CERAi001-A-6 using episomal vectors RCB Wong, SS Hung, S Jackson, V Singh, S Khan, HH Liang, LS Kearns, ... Stem Cell Research 22, 13-15, 2017 | 4 | 2017 |
| An Integrative multi-omics analysis reveals MicroRNA-143 as a potential therapeutic to attenuate retinal angiogenesis JH Wang, YF Chuang, J Chen, V Singh, FL Lin, R Wilson, L Tu, C Ma, ... nucleic acid therapeutics 32 (4), 251-266, 2022 | 2 | 2022 |
| MicroRNA-143 plays a protective role in ischemia-induced retinal neovascularization JH Wang, J Chen, D Ling, L Tu, V Singh, M Riaz, F Li, SM Prea, Z He, ... bioRxiv, 548297, 2019 | 2 | 2019 |
| Applying bioinformatic tools to better understand eye diseases V Singh University of Tasmania, 2020 | | 2020 |
| MicroRNA-143 plays a protective role in ischemia-induced retinal neovascularization. GS Liu, JH Wang, J Chen, L Tu, V Singh, M Riaz, F Li, AW Hewitt, ... ARVO Annual Meeting 60 (9), 3261, 2019 | | 2019 |
| A GENOME‐WIDE CRISPR/CAS9 SCREEN TO IDENTIFY NOVEL THERAPEUTIC TARGETS FOR UVEAL MELANOMA. GSL Fan Li, Vikrant Singh, Vivienne Lu, Jinying Chen, Sandy SC Hung, Joanne ... Clinical & Experimental ophthalmology 46 (S1), 21-35, 2018 | | 2018 |
| A GENOME-WIDE CRISPR/CAS9 SCREEN TO IDENTIFY NOVEL THERAPEUTIC TARGETS FOR UVEAL MELANOMA F Li, V Singh, V Lu, J Chen, SSC Hung, JL Dickinson, P Taberlay, ... CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 46, 28-28, 2018 | | 2018 |
| A genome-wide CRISPR/CAS9 screen to identify novel therapeutic targents for uveal melanoma P Taberlay, V Singh, V Lu, J Chen, SSC Hung, JL Dickinson, AL Cook, ... University Of Tasmania, 2018 | | 2018 |
| Differences in epigenetic age of ocular tissue and the implications for eye disease. AW Hewitt, V Singh, V Januar, A Sexton-Oates, JE Craig, R Saffery ARVO Annual Meeting 58 (8), 2017 | | 2017 |
| B-ANALYSIS RS Cahn, ME Taylor, DM Campbell, V Singh, JF Colombeau, R Meise, ... | | |
Alex HewittUniversity of Tasmania在 utas.edu.au 的电子邮件经过验证
